QuidelOrtho Corp (QDEL)
38.96
-1.06
(-2.65%)
USD |
NASDAQ |
Nov 14, 16:00
38.94
-0.02
(-0.05%)
After-Hours: 20:00
QuidelOrtho Free Cash Flow (Quarterly): 71.40M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 71.40M |
| June 30, 2024 | -133.20M |
| March 31, 2024 | -66.80M |
| December 31, 2023 | 31.80M |
| September 30, 2023 | -1.90M |
| June 30, 2023 | -81.90M |
| March 31, 2023 | 122.90M |
| December 31, 2022 | 107.70M |
| September 30, 2022 | -40.20M |
| June 30, 2022 | 198.50M |
| March 31, 2022 | 478.40M |
| December 31, 2021 | 289.00M |
| September 30, 2021 | -29.90M |
| June 30, 2021 | -253.17M |
| March 31, 2021 | 507.17M |
| December 31, 2020 | 410.32M |
| September 30, 2020 | 47.73M |
| June 30, 2020 | 51.49M |
| March 31, 2020 | 55.30M |
| December 31, 2019 | 39.21M |
| September 30, 2019 | 6.398M |
| June 30, 2019 | 33.74M |
| March 31, 2019 | 27.90M |
| December 31, 2018 | 34.40M |
| September 30, 2018 | 20.99M |
| Date | Value |
|---|---|
| June 30, 2018 | 18.40M |
| March 31, 2018 | 30.86M |
| December 31, 2017 | 6.482M |
| September 30, 2017 | -12.22M |
| June 30, 2017 | -9.926M |
| March 31, 2017 | 25.86M |
| December 31, 2016 | 12.57M |
| September 30, 2016 | -4.786M |
| June 30, 2016 | 1.718M |
| March 31, 2016 | -9.598M |
| December 31, 2015 | 11.60M |
| September 30, 2015 | -7.665M |
| June 30, 2015 | -12.98M |
| March 31, 2015 | 28.90M |
| December 31, 2014 | 15.55M |
| September 30, 2014 | -1.687M |
| June 30, 2014 | -7.517M |
| March 31, 2014 | 18.10M |
| December 31, 2013 | -2.732M |
| September 30, 2013 | -10.51M |
| June 30, 2013 | -14.28M |
| March 31, 2013 | 30.70M |
| December 31, 2012 | 8.288M |
| September 30, 2012 | -2.41M |
| June 30, 2012 | -1.684M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-253.17M
Minimum
Jun 2021
507.17M
Maximum
Mar 2021
90.19M
Average
49.61M
Median
Free Cash Flow (Quarterly) Benchmarks
| Abbott Laboratories | 2.149B |
| Becton Dickinson & Co | 883.00M |
| Repligen Corp | 34.79M |
| Perspective Therapeutics Inc | -9.917M |
| Xtant Medical Holdings Inc | -5.652M |